Johnson & Johnson Aktie
WKN: 853260 / ISIN: US4781601046
24.01.2024 21:31:05
|
JNJ Agrees To $700 Mln Settlement To Resolve Talc Consumer Protection Claims
(RTTNews) - Johnson & Johnson (JNJ) has agreed to a tentative settlement of $700 million to address certain consumer protection claims and a portion of the talc litigation it is currently facing.
Despite two unsuccessful attempts to handle the cases through bankruptcy, J&J plans to pay $700 million to 42 states and the District of Columbia to address claims regarding its talcum-based products, including Johnson's Baby Powder.
Mississippi and New Mexico have not agreed to the settlement, as they are seeking larger settlements through separate lawsuits filed against J&J. The agreement was first reported by Bloomberg two weeks ago, with the company confirming the news to the Wall Street Journal on Tuesday.
The company is still dealing with over 50,000 lawsuits related to talc, primarily from women with ovarian cancer, and fewer cases involving people with mesothelioma. According to the Lawsuit Informational Center, the company has offered $6.9 billion to resolve ovarian cancer claims. J&J is working to address the ovarian cancer and mesothelioma claims separately.
J&J is also facing legal action from shareholders who allege that the company concealed knowledge of its talc products containing cancer-causing asbestos between 2013 and 2018. Despite discontinuing the sale of talc-based baby powder in North America in 2020 and worldwide in 2023, J&J continues to assert the safety of its talc-based products.
The company stopped selling talc-based baby powder in favor of cornstarch-based products, citing an increase in lawsuits and concerns about the safety of the talc product.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Johnson & Johnsonmehr Nachrichten
20.10.25 |
Handel in New York: So steht der Dow Jones aktuell (finanzen.at) | |
15.10.25 |
Dow Jones 30 Industrial-Papier Johnson Johnson-Aktie: So viel hätten Anleger an einem Johnson Johnson-Investment von vor 10 Jahren verdient (finanzen.at) | |
14.10.25 |
J&J-Aktie gibt dennoch nach: Johnson & Johnson rechnet mit höheren Erlösen - Prognose angehoben (dpa-AFX) | |
14.10.25 |
Pluszeichen in New York: Dow Jones-Börsianer greifen zu (finanzen.at) | |
14.10.25 |
Ausblick: Johnson & Johnson gewährt Anlegern Blick in die Bücher (finanzen.net) | |
13.10.25 |
Börse New York in Grün: Dow Jones steigt (finanzen.at) | |
10.10.25 |
Minuszeichen in New York: Dow Jones präsentiert sich zum Handelsende schwächer (finanzen.at) | |
10.10.25 |
Verluste in New York: Dow Jones verbucht am Nachmittag Verluste (finanzen.at) |
Analysen zu Johnson & Johnsonmehr Analysen
Aktien in diesem Artikel
Johnson & Johnson | 166,06 | -0,22% |
|